You can also join our community and choose to have the Research Digest delivered straight to your inbox every month on a Friday afternoon by signing up to our mailing list here.
We appreciate the support of everyone who reads the Research Digest – we encourage regular subscribers to support us with a suggested donation of $2. You can donate here.
Pacing and Rest Position Statement
Pacing and rest are individualised and essential management techniques for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Pacing and rest promote safe levels of activity to manage post-exertional malaise (PEM), the hallmark symptom of ME/CFS.
Webinar Series
As part of Emerge Australia’s commitment to providing up-to-date and evidence based management techniques we have launched a recurring webinar series. You can find those as well all the recent recordings from previous events below. Living with ME/CFS Q&A with Dr Richard Schloeffel OAM World ME/CFS Symposium 2023 Basics of ME/CFS Q&A with Dr Richard
Preparing information for your doctor
Many symptoms of ME/CFS can make communicating difficult. Some people who live with ME/CFS report that at times they struggle to recall information, lose their train of thought easily and find comprehending and processing new information difficult.
What is ME/CFS?
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
ME/CFS – what’s in a name?
Published November 2022 Statement Emerge Australia uses the name ME/CFS as an umbrella term to encompass the varied diagnoses for which PEM is the core feature. Emerge Australia will continue to use this term until the science has definitively concluded whether the illness is one or more separate conditions, and there is consensus on a
GP Education at GPCE in 2023
In 2022, Emerge Australia’s Medical Director, Dr Richard Schloeffel, OAM presented the keynote address at four General Practitioner Conference and Exhibitions (GPCE) with overwhelmingly positive feedback. At these conferences, we demystified the disease by presenting the latest research and providing practical, applicable management options to create a better experience for the patient. Another theme from our
NDIS Petitions 2018 and 2019
In 2018, Emerge Australia launched a paper petition to demand better access to the NDIS for people with ME/CFS. After gathering 1400 signatures, it was tabled in Parliament by Greens MP Adam Bandt on 5 December 2018. We launched the same petition online and over 10,273 people signed. The petition has paved the way for
Telehealth Campaign
In March this year, the federal government made a range of telehealth medical services temporarily available through Medicare. After many years of campaigning for telehealth services for people living with ME/CFS and other chronic illnesses, Emerge Australia and the ME/CFS community have warmly welcomed this change. The current arrangements were originally intended to expire in
Management and Support
Although there are no TGA approved treatments for ME/CFS or Long COVID, healthcare practitioners can do a lot to support people with these conditions. This includes helping patients with:
Energy management: pacing and rest
Step-wise symptom management
Practical support
In addition to our healthcare practitioner information, the Emerge Australia webpage has a wealth of information
Access and equity for the NDIS and the DSP
The National Disability Insurance Scheme (NDIS) aims to give people with disabilities (and their carers) choice and control over the services and support they receive but many people living with ME/CFS face significant challenges gaining access to the scheme and receiving adequate funding. Anecdotal evidence suggests many people with ME/CFS are rejected from the NDIS
Post-Infection disease: Australia’s 10th National Health Priority Area
Emerge Australia strongly advocates for the Federal Department of Health to make post-infection disease Australia’s 10th National Health Priority Area (NHPA). The number of Australians living with post-infection disease is rapidly increasing, predicted to be over half a million by the end of 2022, due to a new cohort of post-infection disease patients: those with
Positioner Test
Sorry, we cannot find the page you are looking for Please try using the menus or search tool at the top of the page or any of the handy shortcuts we have in our footer at the bottom of the page.
Run Melbourne 2023
We’re participating in Run Melbourne 2023. Join now to help reach our goal by running, walking or performing your own activity with us!
Emerge Australia welcomes Tracey Spicer as an Ambassador
We are thrilled to announce that Tracey Spicer, AM BBus(Comm) GAICD, has joined Emerge Australia in an ongoing ambassador role.https://www.emerge.org.au/GetImage.aspx?IDMF=1bd7f269-50e9-45e2-80dd-98297ba7ec05&w=427&h=640&src=mc
Get Involved in Research
Ever been interested in participating in a clinical or non-clinical research study? Want to help further our knowledge of the cause, diagnosis, and treatment of ME/CFS? Here you can find up-to-date information on some of the most relevant ME/CFS research studies that are recruiting in Australia now.
